Sold at select pharmacies offering professional consultations

Hanmi Pharmaceutical said on October 27 that it had launched three “Epislim” health functional food products for weight management.

Images of three Hanmi Pharmaceutical health functional food products, “Episeullim.” Hanmi Pharmaceutical

Images of three Hanmi Pharmaceutical health functional food products, “Episeullim.” Hanmi Pharmaceutical

View original image

The lineup consists of Epislim Muscle, Epislim Boost, and Epislim Skin. All three products contain either a lime-cacao extract complex or green tea extract, ingredients recognized by the Ministry of Food and Drug Safety for their body-fat-reduction benefits, along with other functional ingredients that vary by product.


Epislim Muscle contains turmeric extract, which may help improve muscle strength. Epislim Boost focuses on vitality management, with octacosanol, which may help improve endurance, and B vitamins. Epislim Skin contains low-molecular-weight collagen peptides and biotin to support skin hydration and health. All three products also contain secondary ingredients such as peony extract powder, fermented soybean extract powder, and cudrania fruit powder.


Epislim will be selectively supplied through Onlinepharm, a pharmaceutical distributor affiliated with Hanmi Science, to certain pharmacies that offer specialized consultations on weight loss. Consumers can consult a pharmacist to choose a product suited to their health and weight-management goals.



A Hanmi Pharmaceutical official said, “Epislim was developed with consideration for muscle strength, vitality, and skin health, which consumers are concerned about during weight management.” The official added, “Building on our expertise in obesity and metabolic diseases, we will continue to expand our healthcare solutions for healthy, sustainable weight management.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing